In Part 1 of our medical cannabis in cancer series, guest Marie Parish discussed the rising interest of patients with cancer to explore and use cannabinoids medicinally, shedding light on emerging dosage forms and providing practical education points for patients. Oncology pharmacists are positioned optimally to help patients with cancer navigate medical cannabis or find reliable information about it. In this Part 2 episode, Carlo De Angelis will take you inside Sunnybrook’s pharmacist-led Cannabis Consultation Service, which has been in existence since 2019. Join us for an insightful episode where Carlo’s expertise shines! He delves into the motivations driving patients' interest in medical cannabis, highlights key safety considerations, and shares practical strategies to support responsible cannabis use. Discover the intricacies of implementing a pharmacist-led, patient-centred cannabis consultation service, as Carlo discusses both its challenges and triumphs. If you’re in oncology pharmacy and looking to deepen your understanding of this evolving area in cancer care, this episode is a must-listen!

Learning Objectives:

• Explore why cancer patients may be increasingly curious about plant-based cannabinoids and explore the specific symptoms or side effects they hope to manage
• Describe the structure of the Cannabis Consultation Service, including referral pathways, standardized assessment tools, team roles, typical titration, andfollow up practices
• Examine the processes of implementing a pharmacist-led cannabis consultation service in an institution, from selecting suitable products to addressing clinicianhesitancy, evidence gaps, and patient safety concerns.
• Consider how cannabis evidence generation and broader collaboration may evolve cancer care symptom management over the next decade
• Establish the role of the oncology pharmacist for patients using medical cannabis, and justify why a pharmacist-led service addresses many gaps in care

Publication: Marchese M, Zhu C, Charbonneau LF, et al: Description and disposition of patients with cancer accessing a novel, pharmacist-led cannabis consultation service. JCO Oncol Pract 18:e1777-e1786, 2022